인쇄하기
취소

Hanmi to co-market GSK’s three medicines

Published: 2009-05-13 06:59:00
Updated: 2009-05-13 06:59:00
Hanmi Pharm and GlaxoSmithKline announced on May 8 that the two companies have signed a strategic alliance agreement to co-promote Seretide (fluticasone + salmetelol), Avamys (fluticasone furoate) and Flixonase (fluticasone) in Korea.

Underscoring the important synergy created by this partnership, GSK President Kim Jin-ho said, “We fully anticipate that this partnership will leverage the str...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.